Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins - Wikidata - wikimedia - TriplyDB

Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins

Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins

http://www.wikidata.org/entity/Q24651503

about

Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysis Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.Investigations of apoC-III metabolism using stable isotopes: what information can you acquire and how can you interpret your results?Small heterodimer partner/neuronal PAS domain protein 2 axis regulates the oscillation of liver lipid metabolism.Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease Transcriptome Reveals 1400-Fold Upregulation of APOA4-APOC3 and 1100-Fold Downregulation of GIF in the Patients with Polycythemia-Induced Gastric Injury.Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans.Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.On-chip phenotypic analysis of inflammatory monocytes in atherogenesis and myocardial infarction Antisense technology: an emerging platform for cardiovascular disease therapeutics.The regulation of ApoB metabolism by insulin.Hyperlipoproteinemia type 3: the forgotten phenotype.Apolipoprotein CIII induces monocyte chemoattractant protein-1 and interleukin 6 expression via Toll-like receptor 2 pathway in mouse adipocytes.Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III.Analysis of low-density lipoprotein-associated proteins using the method of digitized native protein mapping.Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.A Plasma α-Tocopherome Can Be Identified from Proteins Associated with Vitamin E Status in School-Aged Children of Nepal.The impact of micronutrient status on health: correlation network analysis to understand the role of micronutrients in metabolic-inflammatory processes regulating homeostasis and phenotypic flexibility.Hepatitis C virus and lipid profiles: more questions than answers?Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions.The plasma proteome identifies expected and novel proteins correlated with micronutrient status in undernourished Nepalese children.Identity-by-Descent Mapping Identifies Major Locus for Serum Triglycerides in Amerindians Largely Explained by an APOC3 Founder Mutation.HDL Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts.Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk.Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk.High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis).Low-density lipoprotein particle diameter and mortality: the Ludwigshafen Risk and Cardiovascular Health Study

P2860

Q26743466-D6154477-F082-4804-9232-75C0C074449F Q26746279-6D71D457-7562-401F-BCC1-DBCC81C601BE Q26864682-81FCD8F7-FD1C-4398-9E7A-E5F3F47A8E9E Q34119914-F7FD69FB-14D7-4CAB-A4E4-D0DF0EB6C567 Q34486059-827B0E92-DE7F-41CD-ADF3-EA2187900A91 Q34551430-7CCD712B-4125-470B-BA20-9F5779EEFC59 Q34955753-93F645DA-3A51-444D-AD5B-069E77B578D6 Q35002010-761CEC3F-16AA-4FFA-B249-50CC135CB9C8 Q35628166-5C146BAD-CBDB-43C3-B63A-78DC1A558611 Q35814753-9A3A8FB2-077A-44F6-B4BC-BFD715A56DA7 Q35839701-88329E4B-E1F3-426B-99B0-E7BC099EF3EA Q35876003-70CAE359-D000-45CC-B5B5-166A7A6C397B Q36377367-6B4B3728-947A-423B-B7CC-BC7A6AF031D1 Q36443768-92A44C8B-8DDE-4F1C-832D-B8AD42DC9390 Q36843331-C6F674AA-A314-4615-AAC8-3B6B125DF944 Q36956660-2F8C4066-A26C-4978-AEBD-532DC08A564C Q36974283-BC085609-FD70-40F7-8AFF-F7C81F9F1C43 Q37117925-07EB0FB8-A3AD-4FFE-B1A2-C30E72FC037B Q37337608-1B93EB41-15AB-4AC2-A705-EDC57B25CDCC Q38110665-A84A0DA5-1CE8-4C04-969C-3B0F97BAD749 Q38235600-779595DE-4315-4596-ADE1-31A53B0EE0A6 Q38860543-3694E1D8-A508-426A-90A4-ED236A121AE8 Q39631869-17AA420E-E202-4E90-9909-7737D2D095C8 Q39770108-E77AB495-7EB0-48C2-82AF-B43A0CD77D0A Q40214593-1C5872A1-3460-4726-80E6-D24D6D394B9D Q40455635-044D5E1E-F566-4B51-8CF5-B4A6530B1AD4 Q42030121-35503FFA-BD16-4A4F-AC05-BBBECD02B4FF Q44983621-2A08278E-DD25-4AA8-95E0-5FDCE0D57F74 Q46803666-B47BA41B-7163-46FC-8047-F2105C2277AE Q47728532-5E4C9D16-136F-46FA-A5AF-31BACF0BB19E Q48570311-6FAC2963-A5C6-4F9E-BC53-5C694FE9F23B Q49834367-98380DE8-2EA0-4A86-9C82-CCA1EE977B6D Q50994675-DF1D0B53-3B96-4B3B-8971-9BD4A96EB3E5 Q52375183-E90E7B97-19FF-4144-AD3A-9C464AFB77E2 Q55056849-F101303F-87A4-48BA-93C5-7F1A92160FE9 Q57315961-68781193-7C46-4C6D-9A7A-38FB126ED984

P2860

Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins

http://www.wikidata.org/entity/Q24651503

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Metabolism of very-low-density ...... ot other small apolipoproteins

@ast

Metabolism of very-low-density ...... ot other small apolipoproteins

@en

Metabolism of very-low-density ...... ot other small apolipoproteins

@nl

type

label

Metabolism of very-low-density ...... ot other small apolipoproteins

@ast

Metabolism of very-low-density ...... ot other small apolipoproteins

@en

Metabolism of very-low-density ...... ot other small apolipoproteins

@nl

prefLabel

Metabolism of very-low-density ...... ot other small apolipoproteins

@ast

Metabolism of very-low-density ...... ot other small apolipoproteins

@en

Metabolism of very-low-density ...... ot other small apolipoproteins

@nl

P1433

Q24651503-BB20B746-EDA0-4BAB-B597-0701451D06B8

P1476

Q24651503-F9C8B3A1-ACC8-4022-B368-267C11B7DF3D

P2093

Q24651503-7581A808-3862-4487-AE8D-8343B48E2CF0

Q24651503-7FA27D8D-BAD9-4EBA-9B09-2C99979C1276

Q24651503-B000AE79-8BAA-4F7E-A9AC-D5B936EBCA16

Q24651503-E066459B-F718-4628-8493-10F783C1C928

Q24651503-EF6B371A-6998-476F-B04F-20B94922051E

P2860

Q24651503-03127428-B96A-4274-903B-2711C66750AA

Q24651503-0B5C74F7-A8BD-4CDC-AFDE-EC03EC7C23AD

Q24651503-1250CB2C-8B8E-438E-A879-5FE590D7C979

Q24651503-1375631F-35B4-4A39-8291-265FF23E6055

Q24651503-1A29D9A7-3E44-4950-9C3F-FCDCCDE29DE2

Q24651503-1AF0572F-E59C-4DC0-90E3-D63DC58CDE19

Q24651503-21C0CD63-2D84-4753-8CC6-82F4C5BF16D6

Q24651503-229FA048-8B81-456C-BD69-BEBAFB72A966

Q24651503-261ADC49-0D0C-4F28-9399-A7771F0A6BFC

Q24651503-2C4A4968-5732-4B67-913C-44864128F644

P304

Q24651503-44EF82D7-DFA6-4BBE-A7CD-49D3B04620BE

P31

Q24651503-36EA0E88-065D-4CEC-86A8-FECCE03561BE

P3181

Q24651503-98F67510-45D6-4B65-A6C7-3D3E8F5CF7CA

P356

Q24651503-48BB5281-0EC4-47DA-AFCA-2035FD72D6D3

P407

Q24651503-60EFF609-601D-4E09-AD38-9838AC419B72

P433

Q24651503-36D63A98-798B-45DF-BBD4-2DEE47AB0777

P478

Q24651503-1FEE2183-43D2-4320-90B3-8BCC2DBFA0E9

P577

Q24651503-2D55FC62-B5C6-4F84-9EAB-7206481C3A12

P698

Q24651503-D6E33CDA-B86A-4BE7-8962-80A8AF528D79

P921

Q24651503-98DBA448-92B7-4A1C-9550-0EBC158F6A33

P932

Q24651503-8E67CCEE-4823-410F-8D26-9DB6FC39B0D8

P3181

P356

ATVBAHA.109.197830

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Metabolism of very-low-density ...... ot other small apolipoproteins

@en

P2093

Carlos O Mendivil

http://www.w3.org/2001/XMLSchema#string

Chunyu Zheng

http://www.w3.org/2001/XMLSchema#string

Frank M Sacks

http://www.w3.org/2001/XMLSchema#string

Jeremy Furtado

http://www.w3.org/2001/XMLSchema#string

Julian Lel

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway

Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice

Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein

Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease.

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.

P304

239-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

299769

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/ATVBAHA.109.197830

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19910636

http://www.w3.org/2001/XMLSchema#string

P921

P932

2818784

http://www.w3.org/2001/XMLSchema#string